Dai Shimizu

2.5k total citations
136 papers, 1.8k citations indexed

About

Dai Shimizu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dai Shimizu has authored 136 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 54 papers in Oncology and 47 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dai Shimizu's work include Gastric Cancer Management and Outcomes (34 papers), Esophageal Cancer Research and Treatment (20 papers) and Cancer-related gene regulation (20 papers). Dai Shimizu is often cited by papers focused on Gastric Cancer Management and Outcomes (34 papers), Esophageal Cancer Research and Treatment (20 papers) and Cancer-related gene regulation (20 papers). Dai Shimizu collaborates with scholars based in Japan and United States. Dai Shimizu's co-authors include Yasuhiro Kodera, Suguru Yamada, Chie Tanaka, Mitsuro Kanda, Tsutomu Fujii, Michitaka Fujiwara, Goro Nakayama, Masahiko Koike, Daisuke Kobayashi and Hiroyuki Sugimoto and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Dai Shimizu

123 papers receiving 1.8k citations

Peers

Countries citing papers authored by Dai Shimizu

Since Specialization

Citations

This map shows the geographic impact of Dai Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Shimizu more than expected).

Fields of papers citing papers by Dai Shimizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dai Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Shimizu. The network helps show where Dai Shimizu may publish in the future.

Co-authorship network of co-authors of Dai Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Dai Shimizu. A scholar is included among the top collaborators of Dai Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dai Shimizu. Dai Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth viaBCL‐2‐mediated intrinsic apoptosis 2023 ·International Journal of Cancer ·(unknown), Mitsuro Kanda, Chie Tanaka, Dai Shimizu, Shinichi Umeda, Hideki Takami, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Goro Nakayama, Yasuhiro Kodera	1
2	Modified Albumin–Bilirubin Grade optimized for risk stratification of patients with stage II–III gastric cancer 2023 ·Surgery Today ·(unknown), Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Dai Shimizu, Chie Tanaka, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera	2
3	Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer 2023 ·Cancers ·Koki Nakanishi, Chie Tanaka, Mitsuro Kanda, (unknown), Kazuhiro Furukawa, Osamu Maeda, Dai Shimizu, (unknown), Naomi Kakushima, (unknown), Hiroki Kawashima, Yuichi Ando, Tomoki Ebata, Yasuhiro Kodera	3
4	Increased STX3 transcript and protein levels were associated with poor prognosis in two independent cohorts of esophageal squamous cell carcinoma patients 2023 ·Cancer Medicine ·(unknown), Mitsuro Kanda, Yusuke Sato, Dai Shimizu, Chie Tanaka, Shinichi Umeda, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Goro Nakayama, Yasuhiro Kodera	2
5	Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers 2023 ·Scientific Reports ·(unknown), Mitsuro Kanda, Dai Shimizu, Shinichi Umeda, Hideki Takami, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka, Goro Nakayama, Yasuhiro Kodera	3
6	Preoperative indocyanine green fluorescence injection to accurately determine a proximal margin during robotic distal gastrectomy 2022 ·Asian Journal of Endoscopic Surgery ·Koki Nakanishi, Chie Tanaka, Mitsuro Kanda, Dai Shimizu, Kazuhiro Furukawa, Michitaka Fujiwara, Hiroki Kawashima, Yasuhiro Kodera	3
7	Drain Amylase Concentrations at 3 h After Gastrectomy Enhance Early Prediction of Postoperative Peripancreatic Inflammatory Fluid Collection 2022 ·World Journal of Surgery ·Koki Nakanishi, Mitsuro Kanda, Chie Tanaka, Shigeomi Takeda, (unknown), Dai Shimizu, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Goro Nakayama, Michitaka Fujiwara, Yasuhiro Kodera	0
8	Prognostic Value of a Modified Albumin–Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection 2022 ·Annals of Surgical Oncology ·(unknown), Mitsuro Kanda, Dai Shimizu, Chie Tanaka, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Masahiko Koike, Yasuhiro Kodera	7
9	Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy 2022 ·Journal of Gastroenterology ·Haruyoshi Tanaka, Mitsuro Kanda, Dai Shimizu, Chie Tanaka, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Goro Nakayama, Yasuhiro Kodera	5
10	E-PASS scoring system serves as a predictor of short- and long-term outcomes in gastric cancer surgery 2021 ·Surgery Today ·Koki Nakanishi, Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Daisuke Kobayashi, Dai Shimizu, Chie Tanaka, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera	5
11	PRAME Expression as a Potential Biomarker for Hematogenous Recurrence of Esophageal Squamous Cell Carcinoma 2019 ·Anticancer Research ·Hayato Baba, Mitsuro Kanda, Koichi Sawaki, Dai Shimizu, Shinichi Umeda, Masahiko Koike, Yasuhiro Kodera, Tsutomu Fujii	10
12	Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines 2019 ·In Vivo ·Takashi Miwa, Mitsuro Kanda, Shinichi Umeda, Haruyoshi Tanaka, Dai Shimizu, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Suguru Yamada, Goro Nakayama, Masahiko Koike, Yasuhiro Kodera	19
13	Cutting-edge evidence of adjuvant treatments for gastric cancer 2018 ·Expert Review of Gastroenterology & Hepatology ·Dai Shimizu, Mitsuro Kanda, Yasuhiro Kodera, Junichi Sakamoto	2
14	Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors 2017 ·Oncology Reports ·Dai Shimizu, Yoshikuni Inokawa, Fuminori Sonohara, (unknown), Shuji Nomoto	11
15	Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study 2016 ·International Journal of Clinical Oncology ·Masahiro Kagabu, Tadahiro Shoji, (unknown), (unknown), (unknown), Fumiharu Miura, Yoshihito Yokoyama, Hideki Tokunaga, Tadao Takano, Tsuyoshi Ohta, Dai Shimizu, Naoki Sato, Shu Soeda, Takafumi Watanabe, Hidekazu Yamada, Hideki Mizunuma, Nobuo Yaegashi, Satoru Nagase, Toru Tase, Toru Sugiyama	8
16	Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer 2016 ·Annals of Surgical Oncology ·Mitsuro Kanda, Dai Shimizu, Tsutomu Fujii, Haruyoshi Tanaka, Yuri Tanaka, (unknown), Masahiro Shibata, Hideki Takami, Ryoji Hashimoto, (unknown), Naoki Iwata, Daisuke Kobayashi, Chie Tanaka, Suguru Yamada, Goro Nakayama, Hiroyuki Sugimoto, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera	17
17	NRAGE promotes the malignant phenotype of hepatocellular carcinoma 2016 ·Oncology Letters ·Dai Shimizu, Mitsuro Kanda, Hiroyuki Sugimoto, (unknown), Hideki Takami, (unknown), Yuri Tanaka, Ryoji Hashimoto, Yukiyasu Okamura, Naoki Iwata, Chie Tanaka, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Masahiko Koike, Shuji Nomoto, Michitaka Fujiwara, Yasuhiro Kodera	25
18	Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor 2014 ·Journal of Gastroenterology ·Hisaharu Oya, Mitsuro Kanda, Hiroyuki Sugimoto, Dai Shimizu, Hideki Takami, Soki Hibino, Ryoji Hashimoto, Yukiyasu Okamura, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Masahiko Koike, Shuji Nomoto, Michitaka Fujiwara, Yasuhiro Kodera	32
19	A Case of Carcinoma of the Ampulla of Vater with Anomaly of the Portal Venous System: Prepancreatic Postduodenal Portal Vein 2014 ·The Japanese Journal of Gastroenterological Surgery ·Dai Shimizu, Tsutomu Fujii, Masaya Suenaga, Yukiko Niwa, (unknown), Mitsuro Kanda, Suguru Yamada, Shin Takeda, Yasuhiro Kodera	5
20	Curative surgery for gastric cancer of the elderly in a Japanese regional hospital. 2013 ·PubMed ·Hisaharu Oya, (unknown), Dai Shimizu, (unknown), (unknown), Yasuhiro Kodera	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact